# Millrose Properties, Inc.: financial statements, quarterly

MRP · NYSE · CIK 2017206 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrp.md) · [Financials](/companies/mrp/financials.md) · [Filings](/companies/mrp/filings.md) · [Insiders](/companies/mrp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mrp/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | [82.7](/filings/0001193125-26-208995.md) | [149](/filings/0001193125-26-332732.md) | [179](/filings/0001193125-25-248748.md) | [190 d](/filings/0002017206-26-000002.md) | [195](/filings/0001193125-26-208995.md) | [197](/filings/0001193125-26-332732.md) |
| Selling, general and administrative | $m | [56.9](/filings/0000950170-25-071540.md) | [59.8](/filings/0000950170-25-100912.md) | [63.7](/filings/0001193125-25-248748.md) | [65.8 d](/filings/0002017206-26-000002.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(57.0)](/filings/0000950170-25-071540.md) | [(59.8)](/filings/0000950170-25-100912.md) | [(63.7)](/filings/0001193125-25-248748.md) | [(65.8) d](/filings/0002017206-26-000002.md) | [45.6](/filings/0001193125-26-208995.md) | [127](/filings/0001193125-26-332732.md) | [153](/filings/0001193125-25-248748.md) | [161 d](/filings/0002017206-26-000002.md) | [166](/filings/0001193125-26-208995.md) | [168](/filings/0001193125-26-332732.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [2.5](/filings/0001193125-26-208995.md) | [10.3](/filings/0001193125-26-332732.md) | [43.7](/filings/0001193125-25-248748.md) | [35.2 d](/filings/0002017206-26-000002.md) | [39.2](/filings/0001193125-26-208995.md) | [40.0](/filings/0001193125-26-332732.md) |
| Income tax | $m | [0.0](/filings/0000950170-25-071540.md) | [0.0](/filings/0000950170-25-100912.md) | [0.0](/filings/0001193125-25-248748.md) | not reported | [4.4](/filings/0001193125-26-208995.md) | [4.8](/filings/0001193125-26-332732.md) | [5.9](/filings/0001193125-25-248748.md) | [5.5 d](/filings/0002017206-26-000002.md) | [5.0](/filings/0001193125-26-208995.md) | [2.5](/filings/0001193125-26-332732.md) |
| Net income | $m | [(57.0)](/filings/0000950170-25-071540.md) | [(59.8)](/filings/0000950170-25-100912.md) | [(63.7)](/filings/0001193125-25-248748.md) | [(65.8) d](/filings/0002017206-26-000002.md) | [39.8](/filings/0001193125-26-208995.md) | [113](/filings/0001193125-26-332732.md) | [105](/filings/0001193125-25-248748.md) | [122 d](/filings/0002017206-26-000002.md) | [123](/filings/0001193125-26-208995.md) | [126](/filings/0001193125-26-332732.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [0.39](/filings/0001193125-26-208995.md) | [0.68](/filings/0001193125-26-332732.md) | [0.63](/filings/0001193125-25-248748.md) | not reported | [0.74](/filings/0001193125-26-208995.md) | [0.76](/filings/0001193125-26-332732.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [0.39](/filings/0001193125-26-208995.md) | [0.68](/filings/0001193125-26-332732.md) | [0.63](/filings/0001193125-25-248748.md) | not reported | [0.74](/filings/0001193125-26-208995.md) | [0.76](/filings/0001193125-26-332732.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0002017206-26-000002.md) | [89.5](/filings/0000950170-25-071540.md) | [66.6](/filings/0000950170-25-100912.md) | [243](/filings/0001193125-25-248748.md) | [35.0](/filings/0001193125-26-332732.md) | [49.3](/filings/0001193125-26-208995.md) | [34.2](/filings/0001193125-26-332732.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [5,465](/filings/0002017206-26-000002.md) | [7,152](/filings/0000950170-25-071540.md) | [7,974](/filings/0000950170-25-100912.md) | [9,024](/filings/0001193125-25-248748.md) | [9,258](/filings/0001193125-26-332732.md) | [9,570](/filings/0001193125-26-208995.md) | [9,707](/filings/0001193125-26-332732.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [307](/filings/0002017206-26-000002.md) | [1,277](/filings/0000950170-25-071540.md) | [2,099](/filings/0000950170-25-100912.md) | [3,165](/filings/0001193125-25-248748.md) | [3,402](/filings/0001193125-26-332732.md) | [3,716](/filings/0001193125-26-208995.md) | [3,855](/filings/0001193125-26-332732.md) |
| Shareholders' equity | $m | [3,775](/filings/0002017206-26-000002.md) | [4,459](/filings/0002017206-26-000002.md) | [4,243](/filings/0000950170-25-100912.md) | [3,769](/filings/0001193125-25-248748.md) | [4,043](/filings/0001193125-25-248748.md) | [5,158](/filings/0001193125-26-332732.md) | [5,876](/filings/0001193125-26-332732.md) | [5,874](/filings/0001193125-26-332732.md) | [5,858](/filings/0001193125-25-248748.md) | [5,856](/filings/0001193125-26-332732.md) | [5,854](/filings/0001193125-26-332732.md) | [5,852](/filings/0001193125-26-332732.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [182](/filings/0000950170-25-071540.md) | [418 d](/filings/0000950170-25-100912.md) | [(340) d](/filings/0001193125-25-248748.md) | [(1,177) d](/filings/0002017206-26-000002.md) | [714](/filings/0001193125-26-208995.md) | [896 d](/filings/0001193125-26-332732.md) | [(1,356) d](/filings/0001193125-25-248748.md) | [3,419 d](/filings/0002017206-26-000002.md) | [797](/filings/0001193125-26-208995.md) | [886 d](/filings/0001193125-26-332732.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | [115 d](/filings/0001193125-25-248748.md) | [121 d](/filings/0002017206-26-000002.md) | [125](/filings/0001193125-26-208995.md) | [126 d](/filings/0001193125-26-332732.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [166](/filings/0001193125-26-208995.md) | [166](/filings/0001193125-26-332732.md) | [166](/filings/0001193125-25-248748.md) | [166](/filings/0001193125-26-208995.md) | [166](/filings/0001193125-26-332732.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.